Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer (Q64375045)

object named as

Karen S Aboody

0 references

author name string

Rachael Mooney

0 references

Asma Abdul Majid

0 references

Jennifer Batalla-Covello

0 references

Diana Machado

0 references

Xueli Liu

0 references

Joanna Gonzaga

0 references

Revathiswari Tirughana

0 references

Mohamed Hammad

0 references

Maciej S Lesniak

Molecular therapy oncolytics

0 references

language of work or name

English

0 references

publication date

29 March 2019

0 references

published in

0 references

volume

0 references

page(s)

79-92

0 references

cites work

High-dose cisplatin therapy in ovarian cancer.

1 reference

12 December 2020

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

12 December 2020

Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.

1 reference

12 December 2020

Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients

1 reference

12 December 2020

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

1 reference

12 December 2020

Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma

1 reference

12 December 2020

Survivin: role in normal cells and in pathological conditions

1 reference

12 December 2020

Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms.

1 reference

12 December 2020

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

1 reference

12 December 2020

1 reference

12 December 2020

Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.

1 reference

12 December 2020

Cisplatin-induced GADD34 upregulation potentiates oncolytic viral therapy in the treatment of malignant pleural mesothelioma

1 reference

12 December 2020

Striking out at disseminated metastases: the systemic delivery of oncolytic viruses.

1 reference

12 December 2020

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

1 reference

12 December 2020

Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus

1 reference

12 December 2020

Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds

1 reference

12 December 2020

Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies

1 reference

12 December 2020

Effects of chemotherapy and/or radiotherapy on survivin expression in ovarian cancer

1 reference

12 December 2020

Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma

1 reference

12 December 2020

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

1 reference

12 December 2020

Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma

1 reference

12 December 2020

Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer.

1 reference

12 December 2020

Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling

1 reference

12 December 2020

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer

1 reference

12 December 2020

Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.

1 reference

12 December 2020

Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma

1 reference

12 December 2020

Effect of liposome size on peritoneal retention and organ distribution after intraperitoneal injection in mice.

1 reference

12 December 2020

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model

1 reference

12 December 2020

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

1 reference

12 December 2020

Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data

1 reference

12 December 2020

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

1 reference

12 December 2020

A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma

1 reference

12 December 2020

A novel CRAd in combination with cisplatin enhanced the antitumor efficacy in ovarian cancer

1 reference

12 December 2020

Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model

1 reference

12 December 2020

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

1 reference

12 December 2020

Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer

1 reference

12 December 2020

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine

1 reference

12 December 2020

Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies

1 reference

12 December 2020

A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy

1 reference

12 December 2020

Evaluating cell lines as tumour models by comparison of genomic profiles

1 reference

12 December 2020

Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction.

1 reference

12 December 2020

Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array

1 reference

12 December 2020

Oncolytic virotherapy for ovarian cancer

1 reference

12 December 2020

Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions

1 reference

12 December 2020

Loss of Survivin in Intestinal Epithelial Progenitor Cells Leads to Mitotic Catastrophe and Breakdown of Gut Immune Homeostasis.

1 reference

12 December 2020

Oncolytic virus as a cancer stem cell killer: progress and challenges

1 reference

12 December 2020

Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.

1 reference

12 December 2020

Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors.

1 reference

12 December 2020